PCVX · Vaxcyte, Inc. · Documents
$63.23
-3.00 (-4.53%)
At close · Oct 21
Return incl. dividend (before tax)
Market Cap
$9.86B
Shares
148.81M
Volume · Oct 21
3.27M
Avg daily vol (3M)
1.95M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | On October 9, 2026, Vaxcyte closed a $575,000,000 1.50% convertible senior notes offering due 2032 and an equity offering, generating approximately $558.7 million and $544.3 million in net proceeds, respectively. | 2026-10-09 | 2026-10-06 | |
| 8-K | — | 2026-10-05 | — | |
| Investor Event Transcript | — | 2026-09-08 | 2026-09-30 | |
| 8-K | — | 2026-09-03 | 2026-08-31 | |
| 8-K | — | 2026-08-05 | — | |
| 10-Q | — | 2026-08-05 | 2026-06-30 | |
| 8-K | — | 2026-07-15 | 2026-07-13 | |
| 8-K | — | 2026-06-23 | 2026-06-17 | |
| 8-K | — | 2026-06-16 | 2026-06-15 | |
| 10-Q | — | 2026-05-06 | 2026-03-31 | |
| 8-K | — | 2026-05-06 | — | |
| ARS | — | 2026-04-23 | 2025-12-31 | |
| DEF 14A | — | 2026-04-23 | 2026-06-15 | |
| DEFA14A | — | 2026-04-23 | — | |
| 8-K | — | 2026-02-24 | — | |
| 10-K | — | 2026-02-24 | 2025-12-31 | |
| 8-K | — | 2026-02-24 | — | |
| 8-K | — | 2026-02-02 | 2026-01-29 | |
| 8-K | — | 2025-12-19 | 2025-12-18 | |
| 8-K | — | 2025-11-04 | — | |
| 10-Q | — | 2025-11-04 | 2025-09-30 | |
| 8-K | — | 2025-09-30 | 2025-09-24 | |
| 8-K | — | 2025-08-06 | — | |
| 10-Q | — | 2025-08-06 | 2025-06-30 | |
| 8-K | — | 2025-06-17 | 2025-06-12 | |
| 10-Q | — | 2025-05-07 | 2025-03-31 | |
| 8-K | — | 2025-05-07 | — | |
| 8-K | — | 2025-05-01 | — | |
| DEFA14A | — | 2025-04-28 | — | |
| DEF 14A | — | 2025-04-28 | 2025-06-12 | |
| ARS | — | 2025-04-28 | 2024-12-31 | |
| PRE 14A | — | 2025-04-18 | 2025-06-12 | |
| 8-K | — | 2025-03-31 | — | |
| 8-K | — | 2025-02-25 | — | |
| 10-K | — | 2025-02-25 | 2024-12-31 | |
| 8-K | — | 2024-11-21 | 2024-11-15 | |
| 8-K | — | 2024-11-05 | — | |
| 10-Q | — | 2024-11-05 | 2024-09-30 | |
| 8-K | — | 2024-09-06 | 2024-09-04 | |
| 8-K | — | 2024-09-03 | — | |
| 10-Q | — | 2024-08-06 | 2024-06-30 | |
| 8-K | — | 2024-08-06 | — | |
| 8-K | — | 2024-07-02 | 2024-06-27 | |
| 8-K | — | 2024-06-10 | 2024-06-06 | |
| S-3ASR | — | 2024-05-24 | — | |
| 10-Q | — | 2024-05-08 | 2024-03-31 | |
| 8-K | — | 2024-05-08 | — | |
| ARS | — | 2024-04-15 | 2023-12-31 | |
| DEF 14A | — | 2024-04-15 | 2024-06-06 | |
| DEFA14A | — | 2024-04-15 | — |
Showing 1–50 of 116 filings
Key facts
CIK
1649094
CUSIP
92243G108
13F (30d)
33 filings
33 filers
Visit website
Investor relations